396 related articles for article (PubMed ID: 27530398)
21. Exploratory clinical trial of combination wound therapy with a gelatin sheet and platelet-rich plasma in patients with chronic skin ulcers: study protocol.
Morimoto N; Kakudo N; Matsui M; Ogura T; Hara T; Suzuki K; Yamamoto M; Tabata Y; Kusumoto K
BMJ Open; 2015 May; 5(5):e007733. PubMed ID: 25968005
[TBL] [Abstract][Full Text] [Related]
22. Skin substitutes for acute and chronic wound healing: an updated review.
Dai C; Shih S; Khachemoune A
J Dermatolog Treat; 2020 Sep; 31(6):639-648. PubMed ID: 30265595
[No Abstract] [Full Text] [Related]
23. Successful treatment of complex traumatic and surgical wounds with a foetal bovine dermal matrix.
Hayn E
Int Wound J; 2014 Dec; 11(6):675-80. PubMed ID: 23452161
[TBL] [Abstract][Full Text] [Related]
24. Wound healing and treating wounds: Chronic wound care and management.
Powers JG; Higham C; Broussard K; Phillips TJ
J Am Acad Dermatol; 2016 Apr; 74(4):607-25; quiz 625-6. PubMed ID: 26979353
[TBL] [Abstract][Full Text] [Related]
25. Skin tissue engineering.
Mansbridge J
J Biomater Sci Polym Ed; 2008; 19(8):955-68. PubMed ID: 18644224
[TBL] [Abstract][Full Text] [Related]
26. Cell suspensions of autologous keratinocytes or autologous fibroblasts accelerate the healing of full thickness skin wounds in a diabetic porcine wound healing model.
Velander P; Theopold C; Bleiziffer O; Bergmann J; Svensson H; Feng Y; Eriksson E
J Surg Res; 2009 Nov; 157(1):14-20. PubMed ID: 19589541
[TBL] [Abstract][Full Text] [Related]
27. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.
Loots MA; Lamme EN; Zeegelaar J; Mekkes JR; Bos JD; Middelkoop E
J Invest Dermatol; 1998 Nov; 111(5):850-7. PubMed ID: 9804349
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic strategies for skin regeneration based on biomedical substitutes.
Chocarro-Wrona C; López-Ruiz E; Perán M; Gálvez-Martín P; Marchal JA
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):484-496. PubMed ID: 30520159
[TBL] [Abstract][Full Text] [Related]
29. Successful application of tissue-engineered skin to refractory ulcers.
Nie X; Cai JK; Yang HM; Xiao HA; Wang JH; Wen N; Zhang YJ; Jin Y
Clin Exp Dermatol; 2007 Nov; 32(6):699-701. PubMed ID: 17725663
[TBL] [Abstract][Full Text] [Related]
30. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities.
Saggini R; Figus A; Troccola A; Cocco V; Saggini A; Scuderi N
Ultrasound Med Biol; 2008 Aug; 34(8):1261-71. PubMed ID: 18394777
[TBL] [Abstract][Full Text] [Related]
31. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
32. The Role of Dermal Matrices in Treating Inflammatory and Diabetic Wounds.
Climov M; Bayer LR; Moscoso AV; Matsumine H; Orgill DP
Plast Reconstr Surg; 2016 Sep; 138(3 Suppl):148S-157S. PubMed ID: 27556755
[TBL] [Abstract][Full Text] [Related]
33. Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: Highlights of a Cochrane systematic review.
Santema TB; Poyck PP; Ubbink DT
Wound Repair Regen; 2016 Jul; 24(4):737-44. PubMed ID: 27062201
[TBL] [Abstract][Full Text] [Related]
34. Oral mucosa: an alternative epidermic cell source to develop autologous dermal-epidermal substitutes from diabetic subjects.
Guzmán-Uribe D; Alvarado-Estrada KN; Pierdant-Pérez M; Torres-Álvarez B; Sánchez-Aguilar JM; Rosales-Ibáñez R
J Appl Oral Sci; 2017; 25(2):186-195. PubMed ID: 28403359
[TBL] [Abstract][Full Text] [Related]
35. Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers.
Atri SC; Misra J; Bisht D; Misra K
Surgery; 1990 Sep; 108(3):508-12. PubMed ID: 2396195
[TBL] [Abstract][Full Text] [Related]
36. Traditional and advanced therapeutic modalities for wounds in the paediatric population: an evidence-based review.
McNamara SA; Hirt PA; Weigelt MA; Nanda S; de Bedout V; Kirsner RS; Schachner LA
J Wound Care; 2020 Jun; 29(6):321-334. PubMed ID: 32530778
[TBL] [Abstract][Full Text] [Related]
37. Heparin-like inhibitory activity to fibroblast growth factor-2 in wound fluids of patients with chronic skin ulcers and its modulation during wound healing.
Landau Z; David M; Aviezer D; Yayon A
Wound Repair Regen; 2001; 9(4):323-8. PubMed ID: 11679141
[TBL] [Abstract][Full Text] [Related]
38. Chronic Wound Healing: A Review of Current Management and Treatments.
Han G; Ceilley R
Adv Ther; 2017 Mar; 34(3):599-610. PubMed ID: 28108895
[TBL] [Abstract][Full Text] [Related]
39. Letter: efficacy of a self-made artificial skin in the treatment of chronic ulcers.
Coto-Segura P; García E; García V; Fueyo-Casado A; Vázquez-López F; Pérez-Oliva N; Meana-Infiesta A
Dermatol Surg; 2007 Mar; 33(3):392-4. PubMed ID: 17338707
[No Abstract] [Full Text] [Related]
40. Pathogenesis of wound healing disorders in the elderly.
Makrantonaki E; Wlaschek M; Scharffetter-Kochanek K
J Dtsch Dermatol Ges; 2017 Mar; 15(3):255-275. PubMed ID: 28252848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
